Japan's Takeda to buy Nimbus' psoriasis drug for as much as $6 bln

Norge Nyheter Nyheter

Japan's Takeda to buy Nimbus' psoriasis drug for as much as $6 bln
Norge Siste Nytt,Norge Overskrifter
  • 📰 Reuters
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 97%

Takeda Pharmaceutical will buy U.S.-based Nimbus Therapeutics' experimental psoriasis drug for up to $6 billion, the Japanese drugmaker said on Tuesday, as it looks to cut reliance on treatments facing loss of patents.

Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo, Japan, July 2, 2018. REUTERS/Kim Kyung-Hoonwill buy U.S.-based Nimbus Therapeutics' experimental psoriasis drug for up to $6 billion, the Japanese drugmaker said on Tuesday, as it looks to cut reliance on treatments facing loss of patents.

The drug, codenamed "NDI-034858", last week showed statistically significant reduction in moderate-to-severe psoriasis in a mid-stage study and is expected to enter late-stage trials next year.The deal involves an upfront payment of $4 billion and an additional $2 billion if the drug achieves certain sales-based milestones, the companies said.

Earlier this month, the company's dengue vaccine was authorized for use in the European Union and Takeda had beefed up its portfolio through a $62 billion deal for Shire in 2019.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

Reuters /  🏆 2. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Japan's Takeda to buy psoriasis drug in up to $6 bln deal with NimbusJapan's Takeda to buy psoriasis drug in up to $6 bln deal with NimbusJapan's Takeda Pharmaceutical said on Tuesday it would acquire Nimbus Therapeutics' drug being developed to treat autoimmune conditions such as psoriasis in up to $6 billion deal.
Les mer »

Monkey export crackdown threatens U.S. pharmaceutical researchMonkey export crackdown threatens U.S. pharmaceutical researchA Cambodian crackdown on the export of non-human primates could threaten drug research in the U.S.
Les mer »

N.J. slugger signs free-agent deal to play in JapanN.J. slugger signs free-agent deal to play in JapanThe MLB Winter Meetings came to a close last week in San Diego, Calif. but the free-agent market remains rich with options.
Les mer »

Japan moves to shed pacifist ways with major defense buildupJapan moves to shed pacifist ways with major defense buildupJapan is seeking to buy hundreds of U.S.-built Tomahawk cruise missiles, as rising tensions with China and North Korea as well as the war in Ukraine convince the government it needs to boost security.
Les mer »

Agrivoltaic farming or solar sharing is growing more popular in JapanSolar sharing helps farmers in Japan adopt sustainable methods — and earn additional money. Presented by Cummins.
Les mer »



Render Time: 2025-03-06 18:29:26